SUPPORTED STARTUPS
Sector: Biotech

Startup Description
Amal Therapeutics SA
Genève 14 - M. Derouazi
Loading...
Development and progression of a new generation of cancer vaccines
ArenaVax AG
Schlieren - D. Pinschewer
Loading...
Revolutionary vaccines for unmet medical needs
BARD1AG SA
Genève - I. Irminger
Loading...
BARDiag
Bicycle Therapeutics Ltd
Lausanne - C. Heinis
Loading...
Novel class of therapeutic molecules to treat a range of serious human diseases.
BioCAP
M. Meyer
Loading...
Microencapsulating agent for functional food products.
Biognosys AG
Schlieren - J. Malmstroem
Loading...
High-throughput system for the development of assays to discover and validate biomarkers on protein basis.
BioScript AG
Basel - S. Dietz
Loading...
Developed for the new emerging bench-top sequencers, our products will bridge the gap towards productive tools and solutions
Biotechnostics GmbH
Basel - J. Kinter
Loading...
Molecular diagnostic tests for personalized medicine.
BioVersys AG
Basel - M. Gitzinger
Loading...
Bacterial transcriptional regulators, which initiate bacterial defense mechanisms causing drug resistance.
Calcification Prevention
Zürich - M. Meier
Loading...
Unique diagnostic blood test
CombaGroup SA
Molondin - B. de Combaud
Loading...
COMBAGROUP implements a new way of growing lettuce.
Davos Diagnostics AG
Davos Platz - R. Crameri
Loading...
Development of highly sensitive easy to use low background fast and competitive diagnostic kits for research and health care applications.
DynaDes AG
Zürich - E. Frugier
Loading...
Dynamic Drug Design deals with the transfer of novel software technology for drug design
ExCellness Biotech SA
Lausanne - P. Wipff
Loading...
Novel surfaces for enhanced cell culture.
FGen GmbH
Zürich - M. Held
Loading...
BPL developed a screening platform employing microbeads for very fast screening of microbial clones
Glycemicon AG
Schwerzenbach - C. Wolfrum
Loading...
Development of a naturally occurring bile acid as functional food
HumanVet
Crissier - A. Tourvieille
Loading...
Drug-delivery biodegradable implant.
InSphero AG
Schlieren - W. Moritz
Loading...
3D microtissues for drug discovery and cell therapy.
Mabimmune Cardiology AG
Schlieren - C. Brokopp
Loading...
Mabimmune aims to prevent myocardial infarction and stroke through early diagnosis and targeted treatment.
Malcisbo AG
Zürich - M. Aebi
Loading...
Platform to identify carbohydrate targets in pathogenic organisms.
MicroDuits GmbH
Zürich - N. Goedecke
Loading...
Miniaturized laboratory equipment for biological applications.
NanoLive
Lausanne - Y. Cotte
Loading...
Nanolive is a worldwide unique technology able to see the activity inside of a living cell in 3D.
Pan Therapeutics
K. Lundstrom
Loading...
Development of novel anticancer drugs based on viral and non-viral gene delivery.
PB
Epalinges - A. Aho
Loading...
Natural breast augmentation using biodegradable microspheres
Phistem Sàrl
Geneva - C. Mas
Loading...
Innovative anti-cancer and stem cell therapies.
PIQUR AG
Basel - V. Cmiljanovic
Loading...
The creation of a pharmaceutical spin-off company that develops and commercializes personalized cancer medicines
Preclin Biosystems AG
Epalinges - B. Ernst
Loading...
Your partner in drug validation: in vivo preclinical testing platform.
ProteoMediX AG
Schlieren - R. Schiess
Loading...
Development of markers for the early detection and monitoring of prostate cancer.
QGel SA
Lausanne - C. Sanctuary
Loading...
A novel hydrogel material.
Qloudlab
Lutry - A. Queval
Loading...
Cloudlab evelops touchscreen technology embedded in Smartphone as a universal Point-of-Care for diagnostics tests.
Sciences University of Surrey Stag Hill
Guildford - A. Gerber
Loading...
Technology for systematic analysis of protein synthesis and implementation in biomarker discovery and drug development
Scientis Pharma SA
Carouge - B. Kasree
Loading...
Development of topical Methima-zole
Stemergie Biotechnology SA
Geneva - V. Clément
Loading...
Stemergie Biotechnology SA targets the roots of cancer in developing treatments and diagnostics against brain tumor cancer stem cells (CSCs)
TransCure Biosciences Holding SA
Genève - P. Nef
Loading...
TransCure Biosciences (TCB) is providing humanized mice for pharmaceutical companies
Virometix AG
Zürich - A. Ghasparian
Loading...
Virometix develops a new generation of vaccines using its Synthetic Virus-Like Particle (SVLP) technology, which enables the creation of a novel type of synthetic nanoparticles.

A PHILANTHROPIC INITIATIVE OF A PRIVATE CONSORTIUM

Turning scientific innovation into entrepreneurial activity and job creation is the basis of societal and economical prosperity. In the very early stages, startups bear very high risks that are neither carried by public money nor by private investors. Supporting seed stage startups fills a crucial gap and is therefore purely philanthropic.
Read more about the Foundation of Founders